With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
Health financing and payment, results-based financing, social protection, conditional cash transfer programs, noncommunicable disease, maternal and child health
Amanda Glassman is chief operating officer and senior fellow at the Center for Global Development and also serves as secretary of the board. Her research focuses on priority-setting, resource allocation and value for money in global health, as well as data for development. Prior to her current position, she served as director for global health policy at the Center from 2010 to 2016, and has more than 25 years of experience working on health and social protection policy and programs in Latin America and elsewhere in the developing world.
Prior to joining CGD, Glassman was principal technical lead for health at the Inter-American Development Bank, where she led policy dialogue with member countries, designed the results-based grant program Salud Mesoamerica 2015 and served as team leader for conditional cash transfer programs such as Mexico’s Oportunidades and Colombia’s Familias en Accion. From 2005-2007, Glassman was deputy director of the Global Health Financing Initiative at Brookings and carried out policy research on aid effectiveness and domestic financing issues in the health sector in low-income countries. Before joining the Brookings Institution, Glassman designed, supervised and evaluated health and social protection loans at the Inter-American Development Bank and worked as a Population Reference Bureau Fellow at the US Agency for International Development. Glassman holds a MSc from the Harvard School of Public Health and a BA from Brown University, has published on a wide range of health and social protection finance and policy topics, and is editor and coauthor of the books Millions Saved: New Cases of Proven Success in Global Health (Center for Global Development 2016), From Few to Many: A Decade of Health Insurance Expansion in Colombia (IDB and Brookings 2010), and The Health of Women in Latin America and the Caribbean (World Bank 2001).
Health spending–whether in developed or developing countries- is all about hard choices. From PEPFAR’s guidance on who gains access when to ARVs, to the $14 billion shortfall for reproductive, maternal, newborn and child health in poor countries this year, to Arizona’s abrupt decision to halt Medicaid reimbursements for organ transplants, deciding how to allocate scarce public and donor money to improve health is a universal ethical, technical, economic and political challenge.
Despite these difficulties, some governments have created transparent, explicit institutional arrangements to help determine health priorities. Among the most prominent is the UK’s National Institute for Health and Clinical Excellence (NICE), which also works outside the UK on an advisory basis.
CGD is pleased to host Sir Andrew Dillon, NICE’s chief executive, and Dr. Kalipso Chalkidou, Director of NICE International, to discuss the relevance of institutions like NICE to improving value for money in health and the characteristics, strengths and limitations of current institutions in the developed and developing world.
The event will be of interest to a broad cross section of professionals interested in the complex problems of priority setting in health and how new technologies are adopted for public funding, whether here in the United States or in the developing world.
Discussion will be introduced and moderated by Amanda Glassman, CGD Director for Global Health Policy.